Erytropoietin behandling kan forbedre kognition ved neuropsykiatriske lidelser

Kristian Skov Kjær; Ida Hageman; Gitta Wörtwein; Martin Balslev Jørgensen; Kamilla Woznica Miskowiak

Erytropoietin behandling kan forbedre kognition ved neuropsykiatriske lidelser

Translated title of the contribution: Erythropoietin treatment may improve cognition in neuropsychiatric disorders

Kristian Skov Kjær, Ida Hageman, Gitta Wörtwein, Martin Balslev Jørgensen, Kamilla Woznica Miskowiak

1 Citation (Scopus)

Abstract

Cognitive dysfunction is a core feature in a range of neuropsychiatric disorders which reduces patients' workforce capacity - the largest socio-economic cost of these disorders. Nevertheless, there is no clinically available medical treatment with robust and enduring efficacy on cognitive deficits in most neuropsychiatric conditions. Recent research has shown that erythropoietin may have beneficial effects on cognitive dysfunction across neuropsychiatric disorders, including bipolar and unipolar disorders, schizophrenia, Parkinson's disease and multiple sclerosis.

Translated title of the contribution	Erythropoietin treatment may improve cognition in neuropsychiatric disorders
Original language	Danish
Article number	V01170037
Journal	Ugeskrift for Laeger
Volume	179
Issue number	22
Pages (from-to)	2-6
Number of pages	5
ISSN	0041-5782
Publication status	Published - 14 Aug 2017

Keywords

English Abstract
Journal Article

Access to Document

http://ugeskriftet.dk/videnskab/erytropoietinbehandling-kan-forbedre-kognition-ved-neuropsykiatriske-lidelser

Cite this

@article{2b26f6d8d6dd44799b9bc88d0c57d3c0,

title = "Erytropoietin behandling kan forbedre kognition ved neuropsykiatriske lidelser",

abstract = "Cognitive dysfunction is a core feature in a range of neuropsychiatric disorders which reduces patients' workforce capacity - the largest socio-economic cost of these disorders. Nevertheless, there is no clinically available medical treatment with robust and enduring efficacy on cognitive deficits in most neuropsychiatric conditions. Recent research has shown that erythropoietin may have beneficial effects on cognitive dysfunction across neuropsychiatric disorders, including bipolar and unipolar disorders, schizophrenia, Parkinson's disease and multiple sclerosis.",

keywords = "English Abstract, Journal Article",

author = "Kj{\ae}r, {Kristian Skov} and Ida Hageman and Gitta W{\"o}rtwein and J{\o}rgensen, {Martin Balslev} and Miskowiak, {Kamilla Woznica}",

year = "2017",

month = aug,

day = "14",

language = "Dansk",

volume = "179",

pages = "2--6",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "22",

}

TY - JOUR

T1 - Erytropoietin behandling kan forbedre kognition ved neuropsykiatriske lidelser

AU - Kjær, Kristian Skov

AU - Hageman, Ida

AU - Wörtwein, Gitta

AU - Jørgensen, Martin Balslev

AU - Miskowiak, Kamilla Woznica

PY - 2017/8/14

Y1 - 2017/8/14

N2 - Cognitive dysfunction is a core feature in a range of neuropsychiatric disorders which reduces patients' workforce capacity - the largest socio-economic cost of these disorders. Nevertheless, there is no clinically available medical treatment with robust and enduring efficacy on cognitive deficits in most neuropsychiatric conditions. Recent research has shown that erythropoietin may have beneficial effects on cognitive dysfunction across neuropsychiatric disorders, including bipolar and unipolar disorders, schizophrenia, Parkinson's disease and multiple sclerosis.

AB - Cognitive dysfunction is a core feature in a range of neuropsychiatric disorders which reduces patients' workforce capacity - the largest socio-economic cost of these disorders. Nevertheless, there is no clinically available medical treatment with robust and enduring efficacy on cognitive deficits in most neuropsychiatric conditions. Recent research has shown that erythropoietin may have beneficial effects on cognitive dysfunction across neuropsychiatric disorders, including bipolar and unipolar disorders, schizophrenia, Parkinson's disease and multiple sclerosis.

KW - English Abstract

KW - Journal Article

M3 - Tidsskriftartikel

C2 - 28869012

SN - 0041-5782

VL - 179

SP - 2

EP - 6

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 22

M1 - V01170037

ER -

Erytropoietin behandling kan forbedre kognition ved neuropsykiatriske lidelser

Abstract

Keywords

Access to Document

Fingerprint

Cite this